Atlas Trials

Study of ST-1898 in Advanced Renal Cell Carcinoma

Clinical trial NCT06127238 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06127238
Sponsor
Beijing Scitech-Mq Pharmaceuticals Limited
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Advanced Renal Cell Carcinoma
Start date
2023-02-07
Primary completion
2025-12-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.